Pharmafile Logo
Pharmafocus logo
Advanced Search
david_hallett

AI firm Exscientia appoints COO and Head of Drug Discovery

January 31, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …

Appointment
512px-gwyneth_paltrow_avp_iron_man_3_paris_2

NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”

January 31, 2020
Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma

NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

January 31, 2020
Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10

This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …

News
citizens_of_wuhan_lining_up_outside_of_a_drug_store_to_buy_masks_during_the_wuhan_coronavirus_outbreak

Two coronavirus cases in the UK as WHO declare outbreak as a ‘global emergency’

January 31, 2020
Medical Communications Chinese Coronavirus, MERS, Wuhan Coronavirus, coronavirus, sara

Two people have tested positive for the Wuhan coronavirus in the UK, they are both part of the same family …

News
shutterstock_159488225

Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer

January 31, 2020
Medical Communications, Research and Development Bayer, orion, pharma

Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …

News
42271822770_6d2a1d533f_b

Exscientia creates first drug using AI

January 31, 2020
Medical Communications AI, AI healthcare, ai pharma

Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …

News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …

News
29565810402_e48022a5ca_b

FDA warns Purell not to claim sanitizers prevent Ebola

January 30, 2020
Business Services Ebola, Ebola africa, Ebola vaccine, hand sanitiser

The FDA has issued a warning letter to Purcell telling them to stop its misleading advertising of their sanitiser products. …

News
smoking

Healthy cells in lungs can repair the damage from smoking

January 30, 2020
Business Services Cancer smoking, cigarettes, lung cancer, lungs, smoking

Human lungs have the ‘magical’ ability to repair the cancerous mutations caused by smoking cigarettes, but only if people quit …

News
shutterstock_36423250

Spring Bank Pharma shuts down HBV drug development following patient death

January 30, 2020
Research and Development Spring Bank, patient death, pharma

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …

News

Johnson & Johnson working on coronavirus vaccine

January 30, 2020
Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus

Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …

News
logo-24-allergan

Allergan opens new Botox plant in Westport

January 29, 2020
Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie

Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …

News
janssen_latest_logo_on_sign_closer

Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer

January 29, 2020
Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …

News

BioIntelliSense’ BioSticker sensor approved by the FDA

January 29, 2020
Research and Development Biosticker, home care, sensors

BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …

News
teva_copy

FDA approves Teva’s Ajovy autoinjector for treatment of migraine

January 29, 2020
Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …

News
british-2746299_960_720

British Airways suspends all flights to mainland China

January 29, 2020
Research and Development British Airways, MERS, Sars, Wuhan Virus, coronavirus, virus

British Airways has ceased all flights to mainland China until 31 January. This comes after the Foreign Office advice against …

News

Prostate Cancer becomes most commonly diagnosed cancer in England

January 28, 2020
Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer

Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …

News
shutterstock_243110086

Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis

January 28, 2020
Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma

Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …

News

Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial

January 28, 2020
Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder

Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …

News
janssen_latest_logo_on_sign

NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression

January 28, 2020
Manufacturing and Production, Sales and Marketing Janssen, NHS, NICE, Spravato, depression

Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026